BEGIN:VCALENDAR VERSION:2.0 PRODID:IEEE vTools.Events//EN CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/Detroit BEGIN:DAYLIGHT DTSTART:20220313T030000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZNAME:EDT END:DAYLIGHT BEGIN:STANDARD DTSTART:20211107T010000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZNAME:EST END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTAMP:20211217T113335Z UID:E6D5AAB3-2B52-452C-B3A0-58B8A478B087 DTSTART;TZID=America/Detroit:20211211T110000 DTEND;TZID=America/Detroit:20211211T123000 DESCRIPTION:Are you considering a career in Artificial Intelligence (AI) in healthcare? This event will be a panel discussion with three successful A I scientists who graduated from the Pittsburgh region.\n\nAI itself has gr eat potential for the benefit of humanity. While AI is not a panacea for h ealthcare problems\, utilizing patient and consumer data could lead to a p recision model approach\, which can help with the diagnosis and prognosis of the disease. We will discuss current innovations that our speakers are a part of as well as discussing the strengths and limitations of AI in hea lthcare. We will also discuss the future potential of AI and the knowledge gap between academia and industry. Further\, we will discuss how Tech com panies are promoting diversity and inclusion to improve AI as a field.\n\n Arielle Fisher\, PhD\n\nDirector of Product\, Genospace\n\nArielle is pass ionate about developing innovative technology to provide real-time decisio n support to healthcare providers. As the Director of Product at Genospace \, a subsidiary of Sarah Cannon Cancer Center and HCA Healthcare\, Arielle has had the unique experience of building a precision medicine platform t o provide highly specific therapeutic options. Her latest work includes ov erseeing a COVID-19 registry with over 150\,000 inpatients for use in a re search consortium established by HCA Healthcare and 11 academic institutio ns. Prior to starting at Genospace\, she received her Ph.D. in Biomedical Informatics from the University of Pittsburgh School of Medicine and her B .A. in Molecular Biology from Bucknell University.\n\nMichael Ding\, PhD\n \nData Scientist\, LifeMine Therapeutics\n\nMichael is excited about the t ransformative potential of data science in healthcare. His latest work foc uses on bringing AI and machine learning to empower drug discovery from eu karyotic microbes. Prior to joining LifeMine\, Michael co-founded a compan y to develop machine learning solutions for precision medicine. Michael ho lds an A.B. in Molecular and Cellular Biology from Harvard University\, an d a Ph.D. in Biomedical Informatics from the University of Pittsburgh Scho ol of Medicine.\n\nGaurav Trivedi\, PhD\n\nAdvanced Innovation\, Philips H ealthcare\n\nGaurav works with Advanced Innovation at Philips Healthcare. He has a Ph.D. in Artificial Intelligence with applications in healthcare. He works on solving problems and challenges during the design and develop ment of intelligent HealthTech. Gaurav serves on the jury of WomenWhoTech\ , a program that awards grants for women-led startups on a rolling basis. He is also the founder of the meditation club at the University of Pittsbu rgh where he continues to serve as an independent advisor.\n\nCo-sponsored by: Engineering in Medicine and Biology\n\nAgenda: \nThis is a 1.5-hour p anel Zoom event\, where the chair and vice-chair of Pittsburgh's Women in Engineering affinity group (Pritika Dasgupta\, PhD and Sruthi Sivakumar) a sk questions to the panel speakers. We will take questions from the audien ce during the last 10-15 minutes.\n\nVirtual: https://events.vtools.ieee.o rg/m/289595 LOCATION:Virtual: https://events.vtools.ieee.org/m/289595 ORGANIZER:pritika@ieee.org SEQUENCE:17 SUMMARY:Panel Discussion: Revolutionizing Healthcare with AI URL;VALUE=URI:https://events.vtools.ieee.org/m/289595 X-ALT-DESC:Description: <br /><p><span style="font-weight: 400\;">Are you c onsidering a career in Artificial Intelligence (AI) in healthcare? This ev ent will be a panel discussion with three successful AI scientists who gra duated from the Pittsburgh region.</span></p>\n<p><span style="font-weight : 400\;">AI itself has great potential for the benefit of humanity. While AI is not a panacea for healthcare problems\, utilizing patient and consum er data could lead to a precision model approach\, which can help with the diagnosis and prognosis of the disease. We will discuss current innovatio ns that our speakers are a part of as well as discussing the strengths and limitations of AI in healthcare. We will also discuss the future potentia l of AI and the knowledge gap between academia and industry. Further\, we will discuss how Tech companies are promoting diversity and inclusion to i mprove AI as a field.</span></p>\n<p>&nbsp\;</p>\n<p><span style="font-wei ght: 400\;"><strong>Arielle Fisher\, PhD</strong></span></p>\n<p><span sty le="font-weight: 400\;"><strong>Director of Product\, Genospace</strong></ span></p>\n<p><span style="font-weight: 400\;">Arielle is passionate about developing innovative technology to provide real-time decision support to healthcare providers. As the Director of Product at Genospace\, a subsidi ary of Sarah Cannon Cancer Center and HCA Healthcare\, Arielle has had the unique experience of building a precision medicine platform to provide hi ghly specific therapeutic options. Her latest work includes overseeing a C OVID-19 registry with over 150\,000 inpatients for use in a research conso rtium established by HCA Healthcare and 11 academic institutions. Prior to starting at Genospace\, she received her Ph.D. in Biomedical Informatics from the University of Pittsburgh School of Medicine and her B.A. in Molec ular Biology from Bucknell University.</span></p>\n<p><strong>Michael Ding \, PhD </strong></p>\n<p><strong>Data Scientist\, LifeMine Therapeutics</s trong></p>\n<p><strong><span style="font-weight: 400\;">Michael is excited about the transformative potential of data science in healthcare. His lat est work focuses on bringing AI and machine learning to empower drug disco very from eukaryotic microbes. Prior to joining LifeMine\, Michael co-foun ded a company to develop machine learning solutions for precision medicine . Michael holds an A.B. in Molecular and Cellular Biology from Harvard Uni versity\, and a Ph.D. in Biomedical Informatics from the University of Pit tsburgh School of Medicine.</span></strong></p>\n<p><br /><strong>Gaurav T rivedi\, PhD</strong></p>\n<p><strong>Advanced Innovation\, Philips Health care</strong></p>\n<p><span style="font-weight: 400\;">Gaurav works with A dvanced Innovation at Philips Healthcare. He has a Ph.D. in Artificial Int elligence with applications in healthcare. He works on solving problems an d challenges during the design and development of intelligent HealthTech. Gaurav serves on the jury of WomenWhoTech\, a program that awards grants f or women-led startups on a rolling basis. He is also the founder of the me ditation club at the University of Pittsburgh where he continues to serve as an independent advisor.</span></p><br /><br />Agenda: <br /><p>This is a 1.5-hour panel Zoom event\, where the chair and vice-chair of Pittsburgh 's Women in Engineering affinity group (Pritika Dasgupta\, PhD and Sruthi Sivakumar) ask questions to the panel speakers. We will take questions fro m the audience during the last 10-15 minutes.</p> END:VEVENT END:VCALENDAR